National Institute for Clinical Excellence and its value judgments

M.D. Rawlins; A.J. Culyer

doi:10.1136/bmj.329.7459.224

National Institute for Clinical Excellence and its value judgments

M.D. Rawlins, A.J. Culyer

Economics

Research output: Contribution to journal › Article › peer-review

Abstract

The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care. NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE’s advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute’s assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.

Original language	English
Pages (from-to)	224-227
Number of pages	4
Journal	BMJ
Volume	329
Issue number	7459
DOIs	https://doi.org/10.1136/bmj.329.7459.224
Publication status	Published - 24 Jul 2004

Bibliographical note

Keywords

HEALTH-CARE
EUROQOL
EQUITY

Access to Document

10.1136/bmj.329.7459.224

culyeraj1.pdf

http://bmj.com/cgi/content/full/329/7459/224

Cite this

@article{b55bfe7249bb41d48b179324cdb9371d,

title = "National Institute for Clinical Excellence and its value judgments",

abstract = "The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care. NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE{\textquoteright}s advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute{\textquoteright}s assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.",

keywords = "HEALTH-CARE, EUROQOL, EQUITY",

author = "M.D. Rawlins and A.J. Culyer",

note = "{\textcopyright} 2004 BMJ Publishing Group Ltd",

year = "2004",

month = jul,

day = "24",

doi = "10.1136/bmj.329.7459.224",

language = "English",

volume = "329",

pages = "224--227",

journal = "BMJ",

issn = "0959-8138",

publisher = "BMJ",

number = "7459",

}

TY - JOUR

T1 - National Institute for Clinical Excellence and its value judgments

AU - Rawlins, M.D.

AU - Culyer, A.J.

PY - 2004/7/24

Y1 - 2004/7/24

N2 - The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care. NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE’s advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute’s assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.

AB - The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care. NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE’s advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute’s assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.

KW - HEALTH-CARE

KW - EUROQOL

KW - EQUITY

U2 - 10.1136/bmj.329.7459.224

DO - 10.1136/bmj.329.7459.224

M3 - Article

SN - 0959-8138

VL - 329

SP - 224

EP - 227

JO - BMJ

JF - BMJ

IS - 7459

ER -